Figure 4.
(A) The results of the differentially expressed analysis between normal cohort and prostate cancer patients; (B) The results of the univariate COX regression analysis; (C) The results of the lasso regression analysis based on the prognostic-related genes; (D) The results of the multivariate COX regression analysis; (E) The heatmap reveals the different group based on the risk score; (F) The survival analysis between low- and high-CAFs group.